Envestnet Asset Management Inc. Has $15.54 Million Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Envestnet Asset Management Inc. increased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 180,802 shares of the company's stock after acquiring an additional 10,876 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.36% of Prestige Consumer Healthcare worth $15,544,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Concurrent Investment Advisors LLC purchased a new stake in Prestige Consumer Healthcare during the first quarter worth about $361,000. Principal Financial Group Inc. grew its holdings in Prestige Consumer Healthcare by 3.2% during the 1st quarter. Principal Financial Group Inc. now owns 264,817 shares of the company's stock worth $22,766,000 after acquiring an additional 8,291 shares in the last quarter. Meritage Portfolio Management raised its holdings in shares of Prestige Consumer Healthcare by 6.8% in the 1st quarter. Meritage Portfolio Management now owns 13,702 shares of the company's stock valued at $1,178,000 after purchasing an additional 876 shares in the last quarter. KBC Group NV raised its holdings in shares of Prestige Consumer Healthcare by 7.4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after purchasing an additional 151 shares in the last quarter. Finally, Bessemer Group Inc. increased its holdings in Prestige Consumer Healthcare by 22.7% in the first quarter. Bessemer Group Inc. now owns 361,958 shares of the company's stock valued at $31,118,000 after buying an additional 66,908 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Analyst Upgrades and Downgrades

PBH has been the topic of a number of recent research reports. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH traded down $0.13 on Monday, hitting $75.65. The company's stock had a trading volume of 425,237 shares, compared to its average volume of 317,247. Prestige Consumer Healthcare Inc. has a 12 month low of $64.94 and a 12 month high of $90.04. The company has a market capitalization of $3.74 billion, a price-to-earnings ratio of 17.63, a price-to-earnings-growth ratio of 2.27 and a beta of 0.43. The stock's 50-day moving average is $82.92 and its two-hundred day moving average is $82.32. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The business had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. During the same quarter in the prior year, the firm posted $1.02 earnings per share. The company's revenue was up 7.0% on a year-over-year basis. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.